Given that JAK-STAT activation confers stemness to prostate adenocarcinoma [21,44], we performed GSEA on our data using the associated gene set and found it was activated after ID2 overexpression (Figure 6C). This evidence concerns the gene ID2 and prostate adenocarcinoma.